Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can we predict who will develop pancreatic cancer from chronic pancreatitis?

NCT ID NCT03324698

Knowledge-focused Sponsor: Changhai Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This large study follows thousands of people with chronic pancreatitis over many years to understand how the disease naturally progresses. Researchers are tracking complications such as diabetes, pancreatic cancer, and bile duct blockages. The goal is to identify risk factors that could help predict and potentially prevent these serious outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors predict which chronic pancreatitis patients are most at risk for serious complications, enabling earlier intervention.
What could go wrong
This is an observational study, not a treatment trial, so it will not test any new therapy. The findings may not apply to populations outside China.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 4,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2000

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Chronic pancreatitis patients in China

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients diagnosed with chronic pancreatitis according to Asia-Pacific consensus Exclusion Criteria: * Pancreatic cancer diagnosed within 2 years after the diagnosis of chronic pancreatitis * Groove pancreatitis * Autoimmune pancreatitis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pancreatitis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic pancreatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic pancreatitis Complication Risk factors

Contacts and locations

Locations

  • Changhai Hospital, Second Military Medical University

    Shanghai, 200433, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.